Evolent Health Inc. (NYSE:EVH) insider Chad Pomeroy sold 55,180 shares of the stock in a transaction dated Wednesday, September 14th. The stock was sold at an average price of $21.54, for a total transaction of $1,188,577.20. Following the transaction, the insider now directly owns 286,370 shares in the company, valued at approximately $6,168,409.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Evolent Health Inc. (NYSE:EVH) opened at 22.47 on Wednesday. The company’s market cap is $1.35 billion. The firm has a 50-day moving average of $24.31 and a 200-day moving average of $17.23. Evolent Health Inc. has a one year low of $8.14 and a one year high of $26.84.

Evolent Health (NYSE:EVH) last announced its earnings results on Thursday, August 4th. The company reported ($0.12) EPS for the quarter, topping the consensus estimate of ($0.16) by $0.04. The firm had revenue of $56.50 million for the quarter, compared to the consensus estimate of $51.96 million. Evolent Health had a negative net margin of 76.55% and a negative return on equity of 5.04%. The business’s quarterly revenue was up 443.3% on a year-over-year basis. During the same quarter last year, the firm posted ($0.95) EPS. On average, analysts predict that Evolent Health Inc. will post ($0.54) EPS for the current year.

Several equities analysts have recently commented on EVH shares. Canaccord Genuity reaffirmed a “buy” rating on shares of Evolent Health in a research report on Thursday, May 26th. FBR & Co increased their price target on shares of Evolent Health from $16.00 to $24.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 13th. Leerink Swann reaffirmed an “outperform” rating and set a $20.00 price target on shares of Evolent Health in a research report on Sunday, July 17th. Finally, Jefferies Group started coverage on shares of Evolent Health in a research report on Tuesday, July 26th. They set a “buy” rating and a $28.00 price target on the stock. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $22.50.

A number of hedge funds and other institutional investors have recently made changes to their positions in EVH. State Street Corp increased its position in shares of Evolent Health by 6.0% in the first quarter. State Street Corp now owns 177,249 shares of the company’s stock valued at $1,872,000 after buying an additional 10,020 shares during the period. Geode Capital Management LLC increased its position in shares of Evolent Health by 1.3% in the first quarter. Geode Capital Management LLC now owns 75,085 shares of the company’s stock valued at $792,000 after buying an additional 948 shares during the period. Blair William & Co. IL increased its position in shares of Evolent Health by 205.5% in the second quarter. Blair William & Co. IL now owns 341,570 shares of the company’s stock valued at $6,558,000 after buying an additional 229,748 shares during the period. Pennant Capital Management LLC increased its position in shares of Evolent Health by 54.2% in the first quarter. Pennant Capital Management LLC now owns 1,361,147 shares of the company’s stock valued at $14,374,000 after buying an additional 478,318 shares during the period. Finally, Renaissance Technologies LLC increased its position in shares of Evolent Health by 84.0% in the first quarter. Renaissance Technologies LLC now owns 259,100 shares of the company’s stock valued at $2,736,000 after buying an additional 118,300 shares during the period. Hedge funds and other institutional investors own 41.96% of the company’s stock.

About Evolent Health

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

5 Day Chart for NYSE:EVH

Receive News & Ratings for Evolent Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.